Johnson & Johnson investing $200 million to develop Ebola vaccine (Video) By: New York Business Journal via Business Journals October 22, 2014 at 16:22 PM EDT Johnson & Johnson plans to invest up to $200 million to accelerate and expand production of an experimental Ebola vaccine... Read More >> Related Stocks: Gsk Plc ADR Johnson & Johnson